Microperimetry and Optical Coherence Tomography (OCT) in Idiopathic Epiretinal Membrane
|ClinicalTrials.gov Identifier: NCT01481987|
Recruitment Status : Completed
First Posted : November 30, 2011
Last Update Posted : November 30, 2011
Purpose: To evaluate macular sensitivity and its correlation with visual acuity and Spectral Domain Optical Coherence Tomography (SD-OCT) in eyes with idiopathic epiretinal membrane (ERM).
Design: Cross sectional case-control series.
Setting: Dijon University Hospital. Patients: Forty nine patients (49 eyes) with idiopathic ERM and twenty-seven healthy patients (27 eyes) as a control group.
Main outcome measurement: Microperimetry, Spectral Domain Optical Coherence Tomography (SD-OCT).
|Condition or disease||Intervention/treatment||Phase|
|Epiretinal Membrane||Procedure: Epiretinal Membrane Surgical treatment||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||76 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Retinal Sensitivity and Optical Coherence Tomography Findings in Eyes With Idiopathic Epiretinal Membrane|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||September 2011|
|Actual Study Completion Date :||September 2011|
Experimental: Epiretinal Membrane
The investigators prospectively included 49 eyes of 49 patients with idiopathic ERM for which surgical treatment had been planned.
Procedure: Epiretinal Membrane Surgical treatment
epiretinal membrane peeling
No Intervention: Control
Subjects with normal visual acuity and OCT profile
- Macular sensitivity [ Time Frame: 12 months ]The objective of this study was to assess macular function by measuring its sensitivity using microperimetry in patients with idiopathic ERM every three months up to one year. We compared the results of macular sensitivity to the best-corrected visual acuity (BCVA) and the OCT data to better understand the structure-function relationship.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01481987
|Ophthalmology Department CHU Dijon|
|Dijon, Burgundy, France, 21000|
|Principal Investigator:||Catherine Creuzot-Garcher, MD, PhD||CHU Dijon|